Bridging quantum mechanics and structure-based drug design.

Area of Science:

• Computational Chemistry
• Biochemistry
• Pharmacology

Background:

• Quantum mechanics (QM) has seen significant advancements in addressing biological problems relevant to pharmaceuticals.
• The QM/MM approach combines QM and molecular mechanics (MM) to study enzymatic catalysis and reaction mechanisms.

Purpose of the Study:

• To review the application of QM and QM/MM methods in studying metalloenzymes of pharmaceutical interest.
• To demonstrate how QM-based methods elucidate ligand-receptor interactions for drug design.
• To explore the use of QM in designing potent inhibitors, such as transition state analogues.

Main Methods:

• Utilizing quantum mechanics (QM) for detailed electronic structure calculations.
• Employing the QM/molecular mechanics (QM/MM) hybrid method to model complex biological systems.
• Analyzing enzymatic reaction mechanisms and ligand-receptor interactions.

Main Results:

• QM and QM/MM studies provide insights into the mechanisms of metallophosphatases and metallo-beta-lactamases.
• These methods successfully elucidate ligand-receptor interactions crucial for drug discovery.
• The design of transition state analogues is facilitated by understanding enzymatic transition states.

Conclusions:

• QM-based methods are powerful tools for understanding biological problems in drug design.
• The application of QM in structure-based drug design is expected to increase significantly.
• Complex QM computations are becoming routine tools for developing new therapeutics.